Changes of Brain Structure in Patients With Metastatic Non-Small Cell Lung Cancer After Long-Term Target Therapy With EGFR-TKI

PURPOSE: Epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) therapy is the routine treatment for patients with metastatic non-small cell lung cancer (NSCLC) harboring positive EGFR mutations. Patients who undergo such treatment have reported cognitive decline during follow-up. Thi...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Front Oncol
Autori principali: Yang, Beisheng, Luo, Chunli, Yu, Min, Zhou, Lin, Tao, Bo, Tang, Biqiu, Zhou, Ying, Zhu, Jiang, Huang, Meijuan, Peng, Feng, Liu, Yongmei, Xu, Yong, Zhang, Yan, Zhou, Xiaojuan, Xue, Jianxin, Li, Yanying, Wang, Yongsheng, Li, Zhiping, Lu, You, Lui, Su, Gong, Youling
Natura: Artigo
Lingua:Inglês
Pubblicazione: Frontiers Media S.A. 2021
Soggetti:
Oncology
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7815525/
https://ncbi.nlm.nih.gov/pubmed/33489880
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.573512
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi